Although, the CFMs seemed to generally inhibit the canonical pathway of NF-κB activation as evidenced by increased expression of ABINs, expression of IκBα and IκBβ proteins were nonetheless down-regulated in CFM-treated NB cells. This evidence concerns the gene NFKBIA and neuroblastoma.